TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
CELC

Celcuity LLC

Healthcare · Biotechnology

80.60$ -5.1% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet CELC
Line item 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
96.7% 97.6% 76.6% 96.9% 94.9% 93.9% 99.4% 99.7% 99.7% 99.8% 99.8%
95.6% 96.7% 8.3% 61.3% 92.4% 89.8% 98.1% 14.0% 16.0% 9.2% 35.5%
95.6% 96.7% 75.7% 95.6% 92.5% 90.0% 98.1% 96.0% 94.4% 95.9% 94.6%
0.9% 1.5% 0.3% 0.1% 0.4% 0.7%
0.0% -0.9% -1.5% -0.3% -0.1% -3.5%
3.3% 2.4% 0.9% 3.1% 5.1% 4.3% 0.4% 0.1%
0.0%
0.0%
5.4% 7.4% 1.8% 2.6% 4.8% 9.7% 20.0% 23.9% 26.9% 52.8% 78.4%
5.4% 7.4% 1.8% 2.5% 4.5% 9.1% 2.9% 3.9% 7.4% 12.9% 9.5%
0.0% 0.9% 1.5% 0.2% 0.1% 0.1% 0.1% 0.0%
4.9% 5.5% 0.2% 0.5% 0.7% 1.7% 1.8% 1.5% 2.7% 3.8% 1.4%
0.0% 17.0% 19.9% 19.4% 39.9% 69.0%
94.6% 92.6% 98.2% 97.4% 95.2% 90.3% 80.0% 76.1% 73.1% 47.2% 21.6%
-94.7% -137.6% -6.3% -36.4% -83.1% -203.1% -65.1% -54.8% -83.7% -110.9% -96.2%
119.1% 110.9% 23.3% 38.9% 50.4% 79.2% 15.6% 8.8% 12.4% 16.1% 11.3%

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?